Search Result "long-term efavirenz"
Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 6 Year: 2015 Page: 811-818
Author(s): Khutso M. Mothapo,Arnt Schellekens,Reinout van Crevel,Monique Keuter,K. Grintjes-Huisman,Peter Koopmans,Andre van der Ven
Effect of Nanotechnology Approaches on Anti-retroviral Molecule: Efavirenz
Journal: Current Organic Chemistry
Volume: 22 Issue: 27 Year: 2018 Page: 2634-2643
Author(s): K. Priya Dharshini,D. Ramya Devi,B.N. Vedha Hari
Long-Term Safety from the Raltegravir Clinical Development Program
Journal: Current HIV Research
Volume: 9 Issue: 1 Year: 2011 Page: 40-53
Author(s): Hedy Teppler, Deborah D. Brown, Randi Y. Leavitt, Peter Sklar, Hong Wan, Xia Xu, Fabio Lievano, Heidi P. Lehman, T. Christopher Mast, Bach-Yen T. Nguyen
Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years
Journal: Current HIV Research
Volume: 10 Issue: 6 Year: 2012 Page: 513-520
Author(s): D. Podzamczer,J. M. Tiraboschi,J. Mallolas,J. Curto,M. A. Cardenes,E. Casas,A. Castro,S. Echevarria,M. Leal,J. C. Lopez Bernaldo de Quiros,S. Moreno,T. Puig,E. Ribera,C. Villalonga,J. L. Gomez-Sirvent,J. A. Garcia-Henarejos,J. Lopez-Aldeguer,P. Barrufet,L. Force,I. Santos,J. Sanz
Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine
Journal: Current HIV Research
Volume: 7 Issue: 5 Year: 2009 Page: 526-532
Author(s): Francisco Rodriguez-Arrondo, Koldo Aguirrebengoa, Joseba Portu, Josefa Munoz, M Asuncion Garcia, Josune Goikoetxea, Eduardo Martinez, Jose A. Iribarren, Nuria Perez-Alvarez, Eugenia Negredo, Bonaventura Clotet
Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?
Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 3 Issue: 2 Year: 2004 Page: 109-133
Author(s): Pere Domingo, Francesc Vidal, Joan Carles Domingo
Long-Term CD4 Cell Count Recovery among Thai Naive HIV-Infected Patients Initiating HAART at Low CD4 Cell Count
Journal: Current HIV Research
Volume: 7 Issue: 3 Year: 2009 Page: 340-345
Author(s): Romanee Chaiwarith, Parichart Salee, Wilai Kotarathitithum, Thira Sirisanthana, Khuanchai Supparatpinyo
Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2186-2195
Author(s): A. Blas-Garcia, J. V. Esplugues, N. Apostolova
Reversal of Major Genotypic Tipranavir Mutations Under Long-Term Treatment with Tipranavir/Ritonavir Itself with Very Limited Optimized Background, During Deep Salvage Antiretroviral Therapy
Journal: Current HIV Research
Volume: 7 Issue: 3 Year: 2009 Page: 311-313
Author(s): Sergio Sabbatani, Roberto Manfredi, Ciro Fulgaro, Isabella Bon
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 3 Year: 2016 Page: 280-287
Author(s): Cindy Bednasz,Amneris E Luque,Barry S Zingman,Margaret A Fischl,Barbara M Gripshover,Charles S Venuto,Jie Gu,Zekun Feng,Robin DiFrancesco,Gene D Morse,Qing Ma